Literature DB >> 8648687

Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins.

C Aberham1, S Weber, W Phares.   

Abstract

Human immunodeficiency virus type 1 mutants that are resistant to inhibition by cyclosporins arise spontaneously in vitro during propagation in a HeLa-CD4+ cell line in the presence of a nonimmunosuppressive analog of cyclosporin A. Interestingly, the phenotype of all of the mutants examined is drug resistant and drug dependent, with both cyclosporin A and its analog. Four independently isolated mutants have been analyzed genetically by construction of recombinant proviruses in the NL4-3 parental strain background and subsequent testing of the chimeric viruses in HeLa cells. The cyclosporin-resistant, cyclosporin-dependent phenotype consistently transfers with a 1.3-kb fragment of gag, within which the four mutants share one of two possible single amino acid exchanges in a proline-rich stretch in the capsid domain of Pr55gag. These mutants provide the first evidence that mutations in human immunodeficiency virus type 1 gag confer resistance to cyclosporins; however, replication is conditional on the presence of the drug. In the T-cell line CEM, replication of the recombinant mutant viruses is also cyclosporin dependent. The drug-dependent replication in HeLa cells is stringent, and in the absence of cyclosporin only revertant viruses with the parental phenotype grow out of cultures infected with cyclosporin-dependent virus. In at least one isolate examined, the revertant phenotype appears to be due to suppressor mutations near the proline-rich region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648687      PMCID: PMC190228     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1.

Authors:  M A Wainberg; A Dascal; N Blain; L Fitz-Gibbon; F Boulerice; K Numazaki; M Tremblay
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

2.  Envelope sequences of two new United States HIV-1 isolates.

Authors:  C Gurgo; H G Guo; G Franchini; A Aldovini; E Collalti; K Farrell; F Wong-Staal; R C Gallo; M S Reitz
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Functional association of cyclophilin A with HIV-1 virions.

Authors:  M Thali; A Bukovsky; E Kondo; B Rosenwirth; C T Walsh; J Sodroski; H G Göttlinger
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

6.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

7.  Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.

Authors:  N Takahashi; T Hayano; M Suzuki
Journal:  Nature       Date:  1989-02-02       Impact factor: 49.962

8.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.

Authors:  A Billich; F Hammerschmid; P Peichl; R Wenger; G Zenke; V Quesniaux; B Rosenwirth
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.

Authors:  S R Bartz; E Hohenwalter; M K Hu; D H Rich; M Malkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.

Authors:  B Rosenwirth; A Billich; R Datema; P Donatsch; F Hammerschmid; R Harrison; P Hiestand; H Jaksche; P Mayer; P Peichl
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

View more
  62 in total

1.  HIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replication.

Authors:  M Srivastava; M Cartas; T A Rizvi; S P Singh; D Serio; V S Kalyanaraman; H B Pollard; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection.

Authors:  Zandrea Ambrose; KyeongEun Lee; Jean Ndjomou; Hongzhan Xu; Ilker Oztop; James Matous; Taichiro Takemura; Derya Unutmaz; Alan Engelman; Stephen H Hughes; Vineet N KewalRamani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.

Authors:  Ron Geller; Marco Vignuzzi; Raul Andino; Judith Frydman
Journal:  Genes Dev       Date:  2007-01-15       Impact factor: 11.361

4.  Magic angle spinning NMR reveals sequence-dependent structural plasticity, dynamics, and the spacer peptide 1 conformation in HIV-1 capsid protein assemblies.

Authors:  Yun Han; Guangjin Hou; Christopher L Suiter; Jinwoo Ahn; In-Ja L Byeon; Andrew S Lipton; Sarah Burton; Ivan Hung; Peter L Gor'kov; Zhehong Gan; William Brey; David Rice; Angela M Gronenborn; Tatyana Polenova
Journal:  J Am Chem Soc       Date:  2013-11-13       Impact factor: 15.419

5.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

6.  Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.

Authors:  Taichiro Takemura; Miyako Kawamata; Miho Urabe; Tsutomu Murakami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Authors:  Yasuhiro Koh; Xiaolin Wu; Andrea L Ferris; Kenneth A Matreyek; Steven J Smith; KyeongEun Lee; Vineet N KewalRamani; Stephen H Hughes; Alan Engelman
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 8.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Authors:  Zandrea Ambrose; Christopher Aiken
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

9.  Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.

Authors:  Brian N Kelly; Sampson Kyere; Isaac Kinde; Chun Tang; Bruce R Howard; Howard Robinson; Wesley I Sundquist; Michael F Summers; Christopher P Hill
Journal:  J Mol Biol       Date:  2007-08-15       Impact factor: 5.469

10.  Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.

Authors:  C Aiken
Journal:  Virology       Date:  1998-08-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.